Sovaldi Archives -

A Chinese research foundation has awarded $2.1m to four teams from Columbia University to identify antiviral drugs that

Could Gilead’s Sovaldi be the answer to COVID-19 coronavirus?

https://pharmaphorum.com/news/could-gileads-sovaldi-be-the-answer-to-coronavirus/

Gilead may be looking for a deal-broker who can kick-start the company’s growth after the lacklustre launch of

Gilead needs deal-maker CEO after Milligan quits

https://pharmaphorum.com/news/gilead-needs-deal-maker-ceo-after-milligan-quits-analyst/

Will company pursue same aggressive pricing strategy in Europe?

Zepatier to add competition to Europe’s hep C market

https://pharmaphorum.com/news/zepatier-add-competition-europes-hep-c-market/

Gilead has led a revolution in curing hepatitis C, but now faces a slowdown.

Many millions still untreated – but hep C boom is already over

https://pharmaphorum.com/views-and-analysis/many-millions-left-untreated-hepatitis-c-boom-already/

Epclusa is first treatment for all six major virus genotypes.

Gilead hopes cut-price pan-genomic hep C combo will revive sales

https://pharmaphorum.com/transversal-categories/us/gilead-looks-new-hepatitis-c-combo-boost-sales/

How do you follow a genuine drug breakthrough, a cure for hepatitis C? Andrew McConaghie visits Gilead’s headquarters

Raising the bar: can Gilead’s next challenge be even bigger than Hep C?

https://pharmaphorum.com/views-and-analysis/raising-the-bar-can-gilead-s-next-challenge-be-even-bigger-than-hep-c/

Sovaldi